Up date in the management of advanced ovarian carcinoma
- 30 September 1999
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 32 (1) , 49-58
- https://doi.org/10.1016/s1040-8428(99)00036-0
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphaide therapy in advanced ovarian adenocarcinomaCancer, 1994
- Surgical staging and cytoreductive surgery of epithelial ovarian cancerCancer, 1993
- Second-look laparotomy and salvage therapy: A research modality only?Gynecologic Oncology, 1992
- Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma.Journal of Clinical Oncology, 1991
- Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1989
- Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinomaGynecologic Oncology, 1988
- A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinomaGynecologic Oncology, 1987
- Prognosis of surgically determined complete responders in advanced ovarian cancerCancer, 1985
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984